Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29713
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMIYAGI, Mariana Yasue Saito-
dc.contributor.authorLATANCIA, Marcela Teatin-
dc.contributor.authorTESTAGROSSA, Leonardo Abreu-
dc.contributor.authorANDRADE-OLIVEIRA, Vinicius de-
dc.contributor.authorPEREIRA, Welbert Oliveira-
dc.contributor.authorHIYANE, Meire Ioshie-
dc.contributor.authorENJIU, Lucas Maceratesi-
dc.contributor.authorPISCIOTTANO, Marcus-
dc.contributor.authorSEELAENDER, Marilia Cerqueira Leite-
dc.contributor.authorCAMARA, Niels Olsen Saraiva-
dc.contributor.authorAMANO, Mariane Tami-
dc.date.accessioned2018-11-21T17:12:48Z-
dc.date.available2018-11-21T17:12:48Z-
dc.date.issued2018-
dc.identifier.citationMOLECULAR IMMUNOLOGY, v.101, p.507-513, 2018-
dc.identifier.issn0161-5890-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29713-
dc.description.abstractCisplatin is a chemotherapy used to treat different types of cancer, such as testicular, bladder and head and neck. Physical exercise has been shown to improve cancer therapy and recently, it was demonstrated to be able to diminish side effects such as acute kidney injury (AKI), a common side effect in cisplatin treatment. In both cases, the modulation of inflammatory cytokines seems to be one of the mechanisms, but little is known about the immune cells in this process. Here, we investigated the role of CD4 + T cells in the AKI protection by physical exercise. We subjected C57B16 mice to long-term physical exercise (EX) before cisplatin treatment. Sedentary groups were used as control (CT). We confirmed that physical exercise decreased AKI by evaluating creatinine and Kim-1 levels, in the serum and kidney respectively. Analyzing the organs weight, we noticed a decrease in sedentary (CIS) and exercised (CIS-EX) cisplatin treated groups. Epididymal and brown adipose tissue weight were decreased in cisplatin treated subjects in comparison to untreated groups, as well as liver and spleen. We then investigated the profile of CD4 + T cells in the spleen and we observed increased levels of Tregs and CD4 + CD25 + cells in CIS group, while CIS-EX presented similar amounts as control groups. Analyzing the kidney lymph nodes, we noticed a decrease of CD4 + cells in both CIS and CIS-EX group. However, a more activated phenotype (CD69 + and CD25 + ) was observed in CIS groups in comparison to CIS-EX group, as well as the presence of Tregs. We then investigated the production of cytokines by these cells and no difference among the groups was observed in cytokines production in splenic CD4 + T cells. However, a clear increase in TNF and IL-10 production was observed in CD4 + T cells from lymph nodes, while CIS-EX group presented similar levels as the control groups. We confirmed that physical exercise was able to diminish cisplatin-induced AKI with concomitant decrease in CD4 + T cell activation.-
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2011/10349-5, 2012/02270-2, 12/50079-0, 2012/10435-1]-
dc.description.sponsorshipAmigos da Oncologia e Hematologia (AmigoH) [Sgpp 2074-14]-
dc.language.isoeng-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.relation.ispartofMolecular Immunology-
dc.rightsrestrictedAccess-
dc.subjectCisplatin-
dc.subjectNephrotoxicity-
dc.subjectExercise-
dc.subjectT cells-
dc.subjectCytokines-
dc.subject.otheracute kidney injury-
dc.subject.othertumor-necrosis-factor-
dc.subject.othert-cells-
dc.subject.otherinhibition-
dc.subject.otherinflammation-
dc.subject.otherlymphocytes-
dc.subject.othermechanisms-
dc.subject.otherinduction-
dc.subject.otherapoptosis-
dc.subject.othernumbers-
dc.titlePhysical exercise contributes to cisplatin-induced nephrotoxicity protection with decreased CD4+T cells activation-
dc.typearticle-
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTD-
dc.identifier.doi10.1016/j.molimm.2018.08.014-
dc.identifier.pmid30144701
dc.subject.wosBiochemistry & Molecular Biology-
dc.subject.wosImmunology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalMIYAGI, Mariana Yasue Saito:Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, SP, Brazil-
hcfmusp.author.externalLATANCIA, Marcela Teatin:Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, SP, Brazil; Hosp Sirio Libanes, Inst Sirio Libanes Ensino & Pesquisa, Rua Daher Cutait,69 7SS Bloco D, BR-01308060 Sao Paulo, SP, Brazil-
hcfmusp.author.externalTESTAGROSSA, Leonardo Abreu:Hosp Sirio Libanes, Clin Pathol Lab, Sao Paulo, SP, Brazil-
hcfmusp.author.externalANDRADE-OLIVEIRA, Vinicius de:Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, SP, Brazil-
hcfmusp.author.externalPEREIRA, Welbert Oliveira:Hosp Israelita Albert Einstein, Fac Israelita Ciencias Saude Albert Einstein, Sch Med, Sao Paulo, SP, Brazil-
hcfmusp.author.externalHIYANE, Meire Ioshie:Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, SP, Brazil-
hcfmusp.author.externalENJIU, Lucas Maceratesi:Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol, Lab Lipid Metab, Sao Paulo, SP, Brazil-
hcfmusp.author.externalPISCIOTTANO, Marcus:Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol, Lab Lipid Metab, Sao Paulo, SP, Brazil-
hcfmusp.author.externalSEELAENDER, Marilia Cerqueira Leite:Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol, Lab Lipid Metab, Sao Paulo, SP, Brazil-
hcfmusp.author.externalAMANO, Mariane Tami:Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Immunobiol Transplants, Sao Paulo, SP, Brazil; Hosp Sirio Libanes, Inst Sirio Libanes Ensino & Pesquisa, Rua Daher Cutait,69 7SS Bloco D, BR-01308060 Sao Paulo, SP, Brazil-
hcfmusp.description.beginpage507-
hcfmusp.description.endpage513-
hcfmusp.description.volume101-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000446283700058-
hcfmusp.origem.id2-s2.0-85051790433-
hcfmusp.publisher.cityOXFORD-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceAkcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011-
hcfmusp.relation.referenceArruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865-
hcfmusp.relation.referenceBatista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023-
hcfmusp.relation.referenceBenedetti G, 2013, MOL PHARMACOL, V84, P128, DOI 10.1124/mol.112.084053-
hcfmusp.relation.referenceBillroth-MacLurg AC, 2016, J IMMUNOL, V197, P2208, DOI 10.4049/jimmunol.1502575-
hcfmusp.relation.referenceDe AK, 2000, J IMMUNOL, V165, P3951, DOI 10.4049/jimmunol.165.7.3951-
hcfmusp.relation.referenceDiehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9-
hcfmusp.relation.referenceFord ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/01.EDE.0000023965.92535.C0-
hcfmusp.relation.referenceFriedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S-
hcfmusp.relation.referenceGarcia JM, 2013, ENDOCRINOLOGY, V154, P3118, DOI 10.1210/en.2013-1179-
hcfmusp.relation.referenceHandzlik MK, 2013, EUR J APPL PHYSIOL, V113, P1839, DOI 10.1007/s00421-013-2614-y-
hcfmusp.relation.referenceHerman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179-
hcfmusp.relation.referenceIchimura T, 2012, KIDNEY INT, V81, P809, DOI 10.1038/ki.2012.11-
hcfmusp.relation.referenceKawai S., 1998, J INFECT CHEMOTHER, V4, P121-
hcfmusp.relation.referenceKinsey GR, 2014, CURR OPIN NEPHROL HY, V23, P9, DOI 10.1097/01.mnh.0000436695.29173.de-
hcfmusp.relation.referenceLi SY, 2012, AM J PHYSIOL-RENAL, V303, pF437, DOI 10.1152/ajprenal.00111.2012-
hcfmusp.relation.referenceLira FS, 2012, HORM METAB RES, V44, P91, DOI 10.1055/s-0031-1299694-
hcfmusp.relation.referenceListon A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605-
hcfmusp.relation.referenceLiu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102-
hcfmusp.relation.referenceNozaki Y, 2011, AM J PHYSIOL-RENAL, V301, pF1098, DOI 10.1152/ajprenal.00193.2011-
hcfmusp.relation.referenceOzkok A, 2016, TOXICOL LETT, V240, P105, DOI 10.1016/j.toxlet.2015.10.028-
hcfmusp.relation.referencePabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786-
hcfmusp.relation.referenceMiyagi MYS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108543-
hcfmusp.relation.referenceSiddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933-
hcfmusp.relation.referenceTimoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33-
hcfmusp.relation.referenceTsuchihashi S, 2007, TRANSPLANTATION, V83, P1628, DOI 10.1097/01.tp.0000266917.39958.47-
hcfmusp.relation.referenceXia ZW, 2008, CURR PHARM DESIGN, V14, P454, DOI 10.2174/138161208783597326-
hcfmusp.relation.referenceYao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e-
hcfmusp.relation.referenceZeynali F., 2015, ASIAN J SPORTS MED, V6-
hcfmusp.relation.referenceZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0-
hcfmusp.relation.referenceZwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus12-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/05
LIM/05 - Laboratório de Poluição Atmosférica Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MIYAGI_Physical_exercise_contributes_to_cisplatininduced_nephrotoxicity_protection_with_2018.PDF
  Restricted Access
publishedVersion (English)2.1 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.